These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 33007583)
1. Comparison of procalcitonin testing to a targeted audit-and-feedback strategy on prescribed durations of therapy for community-acquired pneumonia. Clark LT; Beuschel TS; Buss PM; Jameson AP; Dumkow LE Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115202. PubMed ID: 33007583 [TBL] [Abstract][Full Text] [Related]
2. Impact of Procalcitonin Guidance with an Educational Program on Management of Adults Hospitalized with Pneumonia. Walsh TL; DiSilvio BE; Hammer C; Beg M; Vishwanathan S; Speredelozzi D; Moffa MA; Hu K; Abdulmassih R; Makadia JT; Sandhu R; Naddour M; Chan-Tompkins NH; Trienski TL; Watson C; Obringer TJ; Kuzyck J; Bremmer DN Am J Med; 2018 Feb; 131(2):201.e1-201.e8. PubMed ID: 28947168 [TBL] [Abstract][Full Text] [Related]
3. Procalcitonin-Guided Antibiotic Discontinuation Might Shorten the Duration of Antibiotic Treatment Without Increasing Pneumonia Recurrence. Akagi T; Nagata N; Wakamatsu K; Harada T; Miyazaki H; Takeda S; Ushijima S; Aoyama T; Yoshida Y; Yatsugi H; Wada K; Ueda Y; Fujita M; Watanabe K Am J Med Sci; 2019 Jul; 358(1):33-44. PubMed ID: 31084909 [TBL] [Abstract][Full Text] [Related]
4. Evaluating the utility of procalcitonin and a clinical decision support tool to determine duration of antimicrobial therapy for respiratory tract infections. Pevehouse R; Shah PJ; Chou N; Oolut P; Nair S; Ahmed R Am J Health Syst Pharm; 2024 Aug; 81(Supplement_4):S137-S143. PubMed ID: 38488695 [TBL] [Abstract][Full Text] [Related]
5. Biomarker guided antibiotic stewardship in community acquired pneumonia: A randomized controlled trial. Duijkers R; Prins HJ; Kross M; Snijders D; van den Berg JWK; Werkman GM; van der Veen N; Schoorl M; Bonten MJM; van Werkhoven CH; Boersma WG PLoS One; 2024; 19(8):e0307193. PubMed ID: 39163362 [TBL] [Abstract][Full Text] [Related]
7. Procalcitonin Monitoring as a Guide for Antimicrobial Therapy: A Review of Current Literature. Covington EW; Roberts MZ; Dong J Pharmacotherapy; 2018 May; 38(5):569-581. PubMed ID: 29604109 [TBL] [Abstract][Full Text] [Related]
8. Multistep antimicrobial stewardship intervention on antibiotic prescriptions and treatment duration in children with pneumonia. Rossin S; Barbieri E; Cantarutti A; Martinolli F; Giaquinto C; Da Dalt L; Doná D PLoS One; 2021; 16(10):e0257993. PubMed ID: 34705849 [TBL] [Abstract][Full Text] [Related]
9. Antibiotic stewardship: Early discontinuation of antibiotics based on procalcitonin level in COVID-19 pneumonia. Roy A; Powers HR; Craver EC; Nazareno MD; Yarrarapu SNS; Sanghavi DK J Clin Pharm Ther; 2022 Feb; 47(2):243-247. PubMed ID: 34766357 [TBL] [Abstract][Full Text] [Related]
10. Serum Procalcitonin as A Diagnostic and Prognostic Marker for Bacterial Community - Acquired Pneumonia. El Maghraby HM; Ismail NA; Mohammed HA Egypt J Immunol; 2020 Jan; 27(1):37-44. PubMed ID: 33180386 [TBL] [Abstract][Full Text] [Related]
11. A real-world assessment of procalcitonin combined with antimicrobial stewardship in a community ICU. Langford BJ; Beriault D; Schwartz KL; Seah J; Pasic MD; Cirone R; Chan A; Downing M J Crit Care; 2020 Jun; 57():130-133. PubMed ID: 32145655 [TBL] [Abstract][Full Text] [Related]
12. Procalcitonin and lung ultrasonography point-of-care testing to decide on antibiotic prescription in patients with lower respiratory tract infection in primary care: protocol of a pragmatic cluster randomized trial. Lhopitallier L; Kronenberg A; Meuwly JY; Locatelli I; Dubois J; Marti J; Mueller Y; Senn N; D'Acremont V; Boillat-Blanco N BMC Pulm Med; 2019 Aug; 19(1):143. PubMed ID: 31387559 [TBL] [Abstract][Full Text] [Related]
13. Biological markers to determine eligibility in trials for community-acquired pneumonia: a focus on procalcitonin. Niederman MS Clin Infect Dis; 2008 Dec; 47 Suppl 3():S127-32. PubMed ID: 18986278 [TBL] [Abstract][Full Text] [Related]
14. Procalcitonin to Distinguish Viral From Bacterial Pneumonia: A Systematic Review and Meta-analysis. Kamat IS; Ramachandran V; Eswaran H; Guffey D; Musher DM Clin Infect Dis; 2020 Jan; 70(3):538-542. PubMed ID: 31241140 [TBL] [Abstract][Full Text] [Related]
15. Impact of Procalcitonin Guidance on Management of Adults Hospitalized with Chronic Obstructive Pulmonary Disease Exacerbations. Bremmer DN; DiSilvio BE; Hammer C; Beg M; Vishwanathan S; Speredelozzi D; Moffa MA; Hu K; Abdulmassih R; Makadia JT; Sandhu R; Naddour M; Chan-Tompkins NH; Trienski TL; Watson C; Obringer TJ; Kuzyck J; Walsh TL J Gen Intern Med; 2018 May; 33(5):692-697. PubMed ID: 29404940 [TBL] [Abstract][Full Text] [Related]
16. Procalcitonin algorithm to guide initial antibiotic therapy in acute exacerbations of COPD admitted to the ICU: a randomized multicenter study. Daubin C; Valette X; Thiollière F; Mira JP; Hazera P; Annane D; Labbe V; Floccard B; Fournel F; Terzi N; Du Cheyron D; Parienti JJ; Intensive Care Med; 2018 Apr; 44(4):428-437. PubMed ID: 29663044 [TBL] [Abstract][Full Text] [Related]
17. Adhering to the procalcitonin algorithm allows antibiotic therapy to be shortened in patients with ventilator-associated pneumonia. Beye F; Vigneron C; Dargent A; Prin S; Andreu P; Large A; Quenot JP; Bador J; Bruyere R; Charles PE J Crit Care; 2019 Oct; 53():125-131. PubMed ID: 31228763 [TBL] [Abstract][Full Text] [Related]
18. Procalcitonin for sepsis management: Implementation within an antimicrobial stewardship program. Fugit RV; McCoury JB; Bessesen MT Am J Health Syst Pharm; 2023 May; 80(Suppl 2):S49-S54. PubMed ID: 36371732 [TBL] [Abstract][Full Text] [Related]
19. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Christ-Crain M; Stolz D; Bingisser R; Müller C; Miedinger D; Huber PR; Zimmerli W; Harbarth S; Tamm M; Müller B Am J Respir Crit Care Med; 2006 Jul; 174(1):84-93. PubMed ID: 16603606 [TBL] [Abstract][Full Text] [Related]
20. Impact of an antimicrobial stewardship program on outcomes in patients with community-acquired pneumonia admitted to a tertiary community hospital. Gordon K; Stevens R; Westley B; Bulkow L Am J Health Syst Pharm; 2018 Jun; 75(11 Supplement 2):S42-S50. PubMed ID: 29802178 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]